GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
228 hedge funds and large institutions have $2.14B invested in Genomic Health, Inc. in 2018 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 77 increasing their positions, 66 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
228
Holders Change
+27
Holders Change %
+13.43%
% of All Funds
5.09%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
55
Increased
77
Reduced
66
Closed
27
Calls
$2.97M
Puts
$4.21M
Net Calls
-$1.24M
Net Calls Change
-$1.97M
Top Buyers
Top Sellers
| 1 |
BBA
Baker Bros. Advisors
New York
|
$756M |
| 2 |
Millennium Management
New York
|
$39.8M |
| 3 |
Man Group
London,
United Kingdom
|
$18M |
| 4 |
SIM
Spark Investment Management
New York
|
$0 |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
$6.77M |
